abstracts

0

Page précédente

Abstracts Strasbourg 2004

Type présentation Jour(s) N° Session Auteurs Titre Adresses
Poster 26-28   21  P050 M Kamagaté (1); H Dié-Kacou (1); F Diafouka (2); PT Daubret (1); E Balayssac (1); JC Yavo (1); Intoxication by medicinal plants in Abidjan: clinical, epidemiological and ethnobotanical aspects 
Abstract complet
(1) Département de Pharmacologie Clinique, Université d’Abidjan, Abidjan, Côte d’Ivoire; (2) Département de la Reproduction, Université d’Abidjan, Abidjan, Côte d’Ivoire;
Poster 26-28   21  P051 S Lamy (1); C Noblet (1); N Massy (1); PA Bohu (2); J Augustin (2); B Mihout (2); C Thuillez (1); Gemcitabine-induced polyradiculoneuritis : mitochondrial toxicity? 
Abstract complet
(1) Centre de Pharmacovigilance, CHU de Rouen, Rouen; (2) Département de Neurologie, CHU de Rouen, Rouen;
Poster 26-28   21  P052 A Pathak (1); V Raoul (1); JL Montastruc (1); JM Senard (1); Safety of drugs used for orthostatic hypotension: a prospective observational study in outpatients 
Abstract complet
(1) Service de Pharmacologie, CRPV, Toulouse;
Poster 26-28   21  P053 S Trabelsi (1); S El Aïdli (1); R Daghfous (1); S Kastalli (1); S Sraïri (1); M Lakhal (1); MH Loueslati (1); CH Belkahia (1); Bullous erythema multiforme in a prisoner induced by triexyphenidyl 
Abstract complet
(1) Service de Pharmacovigilance, Centre National de Pharmacovigilance, Tunis, Tunisie;
Poster 26-28   21  P054 S Trabelsi (1); S El Aïdli (1); R Amrani (1); R Daghfous (1); M Lakhal (1); MH Loueslati (1); CH Belkahia (1); Serious bullous cutaneous lesions induced by isoniazid 
Abstract complet
(1) Service de Pharmacovigilance, Centre National de Pharmacovigilance, Tunis, Tunisie;
Poster 26-28   21  P055 E Guitton (1); E Trenado (2); M Lapeyre-Mestre (1); Factors associated with self reported adverse events that have a high or very high impact on every day life 
Abstract complet
(1) Service de Pharmacologie, EA3696, Pharmacoépidémiologie, Faculté de médecine, Toulouse; (2) Etudes Epidémiologiques, Association AIDES, Pantin;
Poster 26-28   21  P056 S Leclerc (1); H Bagheri (1); K Samii (2); JL Montastruc (1); M Lapeyre-Mestre (1); Assessment of the impact of the new French Guidelines on Low Molecular Weight Heparins use in the Toulouse University Hospital 
Abstract complet
(1) Service de Pharmacologie, EA3696, Pharmacoépidémiologie, Faculté de médecine, Toulouse; (2) Department of Anaesthesiology, CHU de Toulouse, Toulouse;
Poster 26-28   21  P057 S Sraïri (1); R Aoudia (1); A Dhaoui (2); S Kastalli (1); D Daghfous (1); M Lakhal (1); MH Loueslati (1); I Mokhtar (2); CH Belkahia (1); Cutaneous lupus erythematosus induced by acebutolol 
Abstract complet
(1) Service de Pharmacovigilance, Centre National de Pharmacovigilance, Tunis, Tunisie; (2) Service de Dermatologie, Hopital Habib Thameur, Tunis, Tunisie;
Poster 26-28   21  P058 C Renzullo (1); S Vernardet (1); B Charpiat (1); S Franchini (2); J Demazière (2); T Vial (3); Preventability assessment of adverse drug events by pharmacists, a pharmacologist and a physician 
Abstract complet
(1) Pharmacie, Hôpital de la Croix-Rousse, Lyon; (2) Urgence d’hospitalisation de courte durée, Hôpital de la Croix-Rousse, Lyon; (3) Centre Régional de Pharmacovigilance, Centre Antipoison, Lyon;
Poster 26-28   21  P059 A. Lillo-Le louët (1); P. Brazille (2); E. Corbé (1); M. H. Pham (1); C. Le Beller (1); E. M. Billaud (1); Voriconazole : therapeutic drug monitoring for adverse drug reaction 
Abstract complet
(1) Pharmacovigilance-Pharmacologie-Toxicologie, H.E.G.P., Paris; (2) Immunologie Clinique, H.E.G.P., Paris;
Poster 26-28   21  P060 MB Valnet Rabier (1); JL Dupond (2); M Paulmier (3); A Petitjean (4); JP Kantelip (1); Phytotherapy and microscopic colitis : a case report implicating Ruscus aculeatus in the development of a collagenous colitis 
Abstract complet
(1) Service de Pharmacovigilance, CHU Saint Jacques, Besançon; (2) Service de Médecine Interne, CHU Jean Minjoz, Besançon; (3) Gastro-Entérologue, Cabinet Paulmier, Besançon; (4) Anatomopathologiste, Centre de Pathologie, Besançon;
Poster 26-28   21  P061 C Cacou (1); I Lacroix (1); JL Montastruc (1); C Damase-Michel (1); Adverse drug reactions in pregnant women 
Abstract complet
(1) Service de Pharmacologie, CHU de Toulouse, Toulouse;
Poster 26-28   21  P062 K Martin (1); F Bentaberry (2); C Dumoulin (2); J Dehais (2); T Schaeverbeke (2); M Longy-Boursier (3); F Lifermann (4); F Haramburu (1); Risk factors for neuropathy during rheumatoid arthritis treatment with leflunomide 
Abstract complet
(1) Centre de Pharmacovigilance, EA 3676 Hôpital Pellegrin, Bordeaux; (2) Service de Rhumatologie, Hopital Pellegrin, Bordeaux; (3) Service de Médecine Interne, Hôpital Saint André, Bordeaux; (4) Service de Médecine Interne, CHG Dax, Dax;
Poster 26-28   21  P063 E Guitton (1); JL Montastruc (1); H Bagheri (1); M Lapeyre-Mestre (1); Study of HVC and HVB infection on antiretroviral drug safety in HIV patients 
Abstract complet
(1) CRPV de Toulouse, EA3696 Pharmacoépidémiologie, Faculté de médecine, Toulouse;
Poster 26-28   21  P064 H Bagheri (1); M Gony (1); JL Montastruc (1); Campaign against Meningococcal Serogroup C disease in Hautes Pyrenees metropolitan area: a prospective follow-up of pharmacovigilance 
Abstract complet
(1) Service de Pharmacologie Clinique, Centre de Pharmacovigilance, Faculté de médecine, Toulouse;
Poster 26-28   21  P065 F. Michenot (1); H. Bagheri (1); JL Montastruc (1); & The French Network Of Pv Centres (1); Adverse Drug Reactions during 2003 summer heat wave: a study in the french Pharmacovigilance database 
Abstract complet
(1) Service de Pharmacologie Clinique, CRPV, Faculté de médecine, Toulouse;
Poster 26-28   21  P066 N Tavassoli (1); H Bagheri (1); Ph Benkemoun (1); L Sailler (2); JL Montastruc (1); PH Arlet (2); Quantification of time devoted to Adverse Drug Reactions assessment during 9 months in an Internal Medicine Department 
Abstract complet
(1) Service de Pharmacologie Clinique- Faculté de Médecine, Centre de Pharmacovigilance, Toulouse; (2) Service de Médecine Interne, Hôpital Purpan, Toulouse;
Poster 26-28   21  P067 ML Laroche (1); P Peyronnet (2); L Arnaud (1); L Merle (1); Severe myalgia with ketoprofen in patients undergoing haemodialysis 
Abstract complet
(1) Centre Régional de Pharmacovigilance, Hôpital Dupuytren, Limoges; (2) ALURAD, Avenue du Buisson, Limoges;
Poster 26-28   21  P068 ML Laroche (1); M Amaniou (1); JP Charmes (2); L Merle (1); Falls and drugs in a geriatric population 
Abstract complet
(1) Centre Régional de Pharmacovigilance, Hôpital Dupuytren, Limoges; (2) Service de Gérontologie clinique, Hôpital Rebeyrol, Limoges;
Poster 26-28   21  P069 F Rollot (1); EM Nazal (1); P Blanche (1); D Salmon (1); F Bavoux (2); L Chauvelot-Moachon (2); Risks with tenofovir : recent data 
Abstract complet
(1) Medecine Interne, Hôpital Cochin, Paris; (2) PharmacoVigilance, Hôpital St Vincent de Paul et Faculté de Médecine, Paris;

Page précédente